eCFR Reference Browser

---

title: "21 CFR §530.10"

source: "https://www.ecfr.gov/current/title-21/section-530.10"

title_number: "21"

volume_number: "6"

chapter_number: "Unknown"

subchapter_code: "E"

subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"

part_code: "530"

part_subject: "EXTRALABEL DRUG USE IN ANIMALS"

subpart_code: "B"

subpart_subject: "Rules and Provisions for Extralabel Uses of Drugs in Animals"

section_number: "530.10"

section_subject: "Provision permitting extralabel use of animal drugs."

cfr_reference: "21 CFR 530.10"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 500 to 599"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

An approved new animal drug or human drug intended to be used for an extralabel purpose in an animal is not unsafe under section 512 of the act and is exempt from the labeling requirements of section 502(f) of the act if such use is:

(a)By or on the lawful written or oral order of a licensed veterinarian within the context of a valid veterinarian-client-patient relationship; and

(b)In compliance with this part.

§530.10 - Provision permitting extralabel use of animal drugs.